Bill Colihan

Q: What is Bill Colihan email address?

Email Bill Colihan at bcolihan@comcast.net and b.colihan@venturevaluation.com. This email is the most updated Bill Colihan's email found in 2026.

Q: How to contact Bill Colihan?

To contact Bill Colihan send an email to bcolihan@comcast.net or b.colihan@venturevaluation.com. (updated on September 02, 2024)

Business Development Director USA & Canada at Biotechgate | Greater Philadelphia

About Bill Colihan

Bill Colihan serves as the Business Development Director for the USA and Canada at Biotechgate, where he leverages his extensive expertise in sales and marketing to drive growth within the life sciences sector. In this pivotal role, Bill spearheads initiatives that connect innovative biotech companies with potential partners and investors, enhancing the visibility of cutting-edge therapeutics and clinical trials. His leadership is instrumental in fostering an active licensing and partnering community, which is crucial for navigating the complexities of the biotech landscape.

With a proven track record in sales strategy and team leadership, Bill excels in developing tailored approaches that resonate with diverse stakeholders, from emerging startups to established pharmaceutical giants. His hands-on experience in sales training and team building has empowered his teams to achieve remarkable revenue growth and improved customer satisfaction. Bill's strategic mindset is complemented by his ability to analyze market trends and identify opportunities for expansion, ensuring that Biotechgate remains at the forefront of the industry.

Key projects under Bill's direction include the enhancement of Biotechgate's comprehensive information service, which integrates sophisticated databases of assets, clinical trials, and financial metrics. By aligning these resources with targeted marketing strategies, he has successfully improved brand awareness and positioned Biotechgate as a vital resource for business development in the life sciences. Bill's commitment to change management and turnaround experience further underscores his capability to adapt and thrive in a dynamic market, making him a valuable asset to the Biotechgate team and the broader biotech community.

Bill Colihan Work